INT230088

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.06
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.20
Pain Relevance 0.12

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

unfolded protein binding (TOR1A) protein folding (TOR1A) endoplasmic reticulum (TOR1A)
nucleus (TOR1A) cytoplasm (TOR1A)
TOR1A (Homo sapiens)
Pain Link Frequency Relevance Heat
Bioavailability 2 98.16 Very High Very High Very High
tolerance 2 83.76 Quite High
Inflammatory response 4 61.44 Quite High
cytokine 10 25.68 Quite Low
Inflammation 22 20.48 Low Low
Infliximab 2 10.56 Low Low
peptic ulcer disease 1 5.00 Very Low Very Low Very Low
Potency 1 5.00 Very Low Very Low Very Low
antagonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Immunization 1 78.88 Quite High
INFLAMMATION 25 61.44 Quite High
Celiac Disease 58 59.64 Quite High
Diabetes Mellitus 3 40.40 Quite Low
Disease 66 38.08 Quite Low
Crohn's Disease 3 5.36 Low Low
T-cell Lymphoma 6 5.00 Very Low Very Low Very Low
Enteropathy 5 5.00 Very Low Very Low Very Low
Infection 5 5.00 Very Low Very Low Very Low
Stress 5 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
By building these inhibitors from a gluten peptide scaffold, it is hoped that such DQ2 blockers will possess similar proteolytic resistance, bioavailability, and affinity for DQ2 as immunotoxic gluten peptides.
Negative_regulation (blockers) of DQ2 associated with bioavailability
1) Confidence 0.06 Published 2008 Journal PLoS Pathogens Section Body Doc Link PMC2323203 Disease Relevance 0.20 Pain Relevance 0.12

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox